Nisa Investment Advisors
CRBP icon

Nisa Investment Advisors’s Corbus Pharmaceuticals CRBP Stock Holding History

Nisa Investment Advisors’s Portfolio CRBP Stock Details CRBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.69K Hold
287
– – ﹤0.01% 2714
2026
Q1 		$2.69K Hold
287
– – ﹤0.01% 2567
2025
Q4 		$2.34K Hold
287
– – ﹤0.01% 2585
2025
Q3 		$3.63K Hold
287
– – ﹤0.01% 2509
2025
Q2 		$1.98K Buy
+287
New +$2.08K ﹤0.01% 2609
2025
Q1 		– Sell
-54
Closed -$637 – 3002
2024
Q4 		$637 Buy
54
+25
+86% +$419 ﹤0.01% 2779
2024
Q3 		$598 Buy
+29
New +$1.48K ﹤0.01% 2690

Other funds holding CRBP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
QC
Quadrature Capital London, United Kingdom $11.7B AUM 87.29% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Nisa Investment Advisors's CRBP Position: Q2 2026 in Review

Nisa Investment Advisors held its Corbus Pharmaceuticals (CRBP) position steady in Q2 2026 at 287 shares worth $2.69K. The position accounts for ﹤0.01% of the portfolio, ranked #2714.

Nisa Investment Advisors first reported a position in CRBP in Q3 2024 and has held it in 7 quarters since. The position peaked at $3.63K in Q3 2025. 35 funds tracked by Wall St. Rank hold CRBP as of Q2 2026.

  • Nisa Investment Advisors held 287 shares of Corbus Pharmaceuticals worth $2.69K as of Q2 2026.
  • Nisa Investment Advisors left its Corbus Pharmaceuticals share count unchanged in Q2 2026.
  • Corbus Pharmaceuticals made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2714 holding.
  • Nisa Investment Advisors first reported a position in Corbus Pharmaceuticals in Q3 2024 and has held it in 7 quarters since.
  • Nisa Investment Advisors's Corbus Pharmaceuticals position peaked at $3.63K in Q3 2025.
  • 35 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.